drugset / Trial / NCT02737995

Iron Stores and Skeletal Muscle Metabolism in Chronic Heart Failure

NCT02737995

Phase 1 Completed 8 enrolled NYU Langone Health
NaSingle-groupOpen-labelTreatment

Summary

Iron deficiency may contribute to exercise intolerance by altering mitochondrial oxidative capacity in skeletal muscle. Functional iron deficiency is common in heart failure patients, but the relationship to exercise intolerance and mitochondrial oxidative capacity is unknown. This is a pilot study to determine the feasibility of the use of specialized 31P-MRS and MRI techniques for measurement of skeletal muscle bioenergetics in patients with heart failure with and without functional iron deficiency.

Timeline

Start
2015-05
Primary completion
2016-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 750 mg Intravenous

Indications